Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Weight Reduction Programs × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Lymphedema 1 Breast Neoplasms 1

Interventions

Trastuzumab 318 Paclitaxel 304 Cyclophosphamide 285 Docetaxel 262 Capecitabine 174 Doxorubicin 165 Letrozole 151 Tamoxifen 133 Carboplatin 120 Fulvestrant 111 Bevacizumab 105 Lapatinib 103 Anastrozole 103 exemestane 102 Radiotherapy 94 Gemcitabine 93 Epirubicin 91 Surveys and Questionnaires 70 Vinorelbine 68 Exercise 68 Fluorouracil 67 palbociclib 66 Albumin-Bound Paclitaxel 63 pertuzumab 60 Filgrastim 59 Magnetic Resonance Spectroscopy 54 eribulin 53 130-nm albumin-bound paclitaxel 53 Everolimus 52 Cisplatin 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04974268 2025-02-14

EJERDIETLIF

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Phase NA Completed

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡